Education
About Us
Working with TipRanks
Follow Us
Mangoceuticals, Inc. (MGRX)
NASDAQ:MGRX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | $ 615.87K | $ 731.49K | $ 8.94K | $ 0.00 |
| Gross Profit | $ 379.96K | $ 431.50K | $ 4.85K | $ 0.00 |
| Operating Income | $ -7.97M | $ -9.22M | $ -1.99M | $ -17.52K |
| EBITDA | $ -7.96M | $ -8.09M | $ -1.99M | $ -17.52K |
| Net Income | $ -8.71M | $ -9.21M | $ -2.00M | $ -17.70K |
| Balance Sheet | ||||
| Cash & Short-Term Investments | $ 58.65K | $ 739.01K | $ 682.86K | $ 22.55K |
| Total Assets | $ 15.37M | $ 1.05M | $ 1.00M | $ 22.55K |
| Total Debt | $ 214.96K | $ 128.68K | $ 352.87K | $ 39.27K |
| Net Debt | $ 156.31K | $ -610.33K | $ -330.00K | $ 16.72K |
| Total Liabilities | $ 1.43M | $ 276.04K | $ 389.26K | $ 39.27K |
| Stockholders' Equity | $ 13.95M | $ 774.75K | $ 614.03K | $ -16.72K |
| Cash Flow | ||||
| Free Cash Flow | $ -4.86M | $ -7.00M | $ -1.39M | $ -17.52K |
| Operating Cash Flow | $ -4.86M | $ -7.00M | $ -1.35M | $ -17.52K |
| Investing Cash Flow | $ 65.00K | $ -3.52K | $ -43.10K | $ 0.00 |
| Financing Cash Flow | $ 4.13M | $ 7.06M | $ 2.05M | $ 40.07K |
Mangoceuticals, Inc. Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.